Related Experiment Video
Updated: Jun 19, 2026

Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile
Published on: September 20, 2024
Comparison of postoperative wavefront aberrations after NIDEK CXIII optimized aspheric transition zone treatment and
1Magrabi Eye & Ear Center, Dammam, Saudi Arabia. mohamedhantera30@gmail.com
Purpose:
To compare higher order aberrations of aspheric or wavefront-guided myopic LASIK.
Methods:
This was a prospective, randomized study of a myopic LASIK cohort that was subdivided into two groups; 12 eyes were treated with the optimized aspheric transition zone algorithm (OATz group) and 11 eyes were treated with wavefront-guided optimized path difference custom aspheric treatment (OPDCAT group). Corneal asphericity and higher order aberrations root-mean-square were compared between groups before, 1 month, and 3 months after LASIK. Student t test was used to assess differences between groups. P<.05 was considered statistically significant.
Results:
At 3 months postoperatively, all eyes in both groups had spherical equivalent refraction of +/-0.50 diopters (D). Mean higher order aberration increased by 0.18 microm postoperatively in the OATz group (P<.05) and decreased by 0.04 microm in the OPDCAT group (P=.819). A statistically significant increase in spherical aberration was noted in the OATz group only (P<.05). Asphericity showed a statistically significant difference between the two groups postoperatively (P<.05). There was a greated tendency for increased higher order aberrations in eyes with <0.30 microm of higher order aberrations preoperatively in the OPDCAT group. The reverse tendency was observed in the OATz group.
Conclusions:
OPDCAT induced minimal changes in spherical aberration due to lower changes in corneal asphericity compared to the OATz group. Eyes with <0.30 microm of higher order aberrations preoperatively are likely better candidates for the OATz algorithm than OPDCAT.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
